Clinical Trials Logo

Filter by:
NCT ID: NCT04995601 Completed - Orthopedic Disorder Clinical Trials

Wearable Technology to Reduce Risk of DVT and Increase Patient Compliance

SBIR2
Start date: April 1, 2022
Phase: N/A
Study type: Interventional

The primary purpose of this study is to conduct a multi-site clinical trial of the Recovery Force Movement and Compressions (RF MAC) System. The study is a randomized comparative study of DVT prophylaxis using either standard IPC (Group 1) or the RF MAC system (Group 2) in 300 patients after TJR surgery at two study sites: Tufts Medical Center (Boston, Massachusetts) and Eskenazi Hospital (Indianapolis, Indiana). This study is funded by a Phase II SBIR awarded to Recovery Force from the National Institutes of Health, National Heart, Lung and Blood Institute (R44-HL132624-02).

NCT ID: NCT04995497 Completed - Clinical trials for Erector Spinae Plane Block

Intravenous(IV) vs. Erector Spinae Plane Blocks in Cardiac Surgery

Start date: August 15, 2021
Phase: Phase 2
Study type: Interventional

Interfascial plane blocks have been developed for analgesia, among which the erector spinae plane (ESP) has gained popularity. The ESP block has been hypothesized to provide truncal analgesia by spread of local anesthetic into the paravertebral space. Recent studies have contested this idea showing unreliability in the spread of the local anesthetic into the paravertebral space.

NCT ID: NCT04995484 Completed - Clinical trials for Moderate Hepatic Impairment

Belzutifan (MK-6482) Hepatic Impairment Study (MK-6482-020)

Start date: June 24, 2022
Phase: Phase 1
Study type: Interventional

The primary purpose of this study is to compare the plasma pharmacokinetics (PK) of belzutifan (MK-6482) following a single oral 80 mg dose of belzutifan in participants with moderate hepatic impairment to that of healthy matched control participants. This study will also evaluate the safety and tolerability of a single oral 80 mg dose of belzutifan in participants with moderate hepatic impairment.

NCT ID: NCT04995315 Completed - Clinical trials for Pyruvate Kinase Deficiency

Pyruvate Kinase Deficiency Global Longitudinal Registry Substudy of Protocol AG348-C-008

Start date: July 2, 2021
Phase:
Study type: Observational

This is a substudy of Study AG348-C-008, an observational, longitudinal, multicenter, global registry that aims to better understand the longitudinal clinical implications of pyruvate kinase deficiency (PK deficiency). The primary purpose of this study is to describe the cognition of participants with PK deficiency, as objectively measured by the Cogstate Brief Battery (CBB).

NCT ID: NCT04995237 Completed - Quality of Life Clinical Trials

RHWP Prescription Produce Plan

PPP
Start date: August 5, 2021
Phase: N/A
Study type: Interventional

The purpose of this research study is to find out if access to fresh produce along with individual goal setting and education influences vegetable consumption, self-management [self-efficacy], resilience, or quality of life. Researcher think access to fresh produce along with individual goal setting and education, may improve all of the above. This study will allow them to learn more about it.

NCT ID: NCT04995211 Completed - Clinical trials for Metabolism and Nutrition Disorder

Validity and Reliability of Commercially Available Metabolic Carts

Start date: July 22, 2021
Phase:
Study type: Observational

The validity (by alcohol burning and gas infusions) and reliability (day-to-day variability in healthy subjects) of six metabolic carts will be compared.

NCT ID: NCT04995055 Completed - Visual Acuity Clinical Trials

Evaluation of Multifocal Contact Lens Designs With and Without an HEV Blocker on Visual Function

Start date: October 25, 2021
Phase: N/A
Study type: Interventional

This is a single-masked, bilateral, controlled, randomized, 2x2 crossover, non-dispensing clinical trial to characterize the effects of an HEV-Blocker on several measures of visual function in a presbyopic population.

NCT ID: NCT04994782 Completed - Terminal Illness Clinical Trials

GAMification to Encourage End-Of-Life Discussions Between ICD Patients and Caregivers

GAME-EOL
Start date: January 20, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the feasibility and efficacy of the GAMification to Encourage End-Of-Life (GAME-EOL) intervention, which uses the Hello Game program to encourage and facilitate quality end-of-life (EOL) discussions between implantable cardioverter defibrillators (ICD) recipients and family members of ICD recipients.

NCT ID: NCT04994769 Completed - Clinical trials for Overweight and Obesity

The Effect of Extended Use of the EPITOMEE CAPSULE (ELECT)

Start date: August 31, 2021
Phase: N/A
Study type: Interventional

The Effect of Extended Use of the Epitomee Capsule on BodyWeight in subjects with Overweight and Obesity with and without Prediabetes

NCT ID: NCT04994691 Completed - Clinical trials for Health Care Utilization

Effect of Varied Outreach Methods on Appointment Scheduling and Appointment Completion Using MyChart

Start date: July 30, 2021
Phase: N/A
Study type: Interventional

Our objective is to determine the effectiveness of varied outreach methods (e.g. standard versus tailored MyChart messaging) to children age 6-17 years old who are due for a WCC visit and don't have one scheduled in the next 45 days on the outcomes of appointment scheduling and appointment completion.